[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342934-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342934-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","regulator-of-g-protein-signaling-16-restrains-apoptosis-in-colorectal-cancer-through-disrupting-traf6-tab2-tak1-jnkp38-mapk-signaling","Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling","","Colorectal cancer (CRC) remains a leading cause of cancer-related death, with limited biomarkers and therapeutic targets. RGS proteins modulate GPCR downstream signaling, yet RGS family roles in cancers are unclear. This study profiles RGS protein expression in CRC and identifies RGS16 as a diagnostic and therapeutic candidate. Analysis of 899 CRC tissues shows elevated RGS16 linked to clinicopathological features and poorer prognosis. Functional experiments demonstrate that RGS16 promotes CRC progression and limits apoptosis by disrupting TRAF6-TAB2-TAK1 recruitment, suppressing JNK/p38-mediated apoptosis in CRC cells, including organoid models, supporting clinical translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/regulator-of-g-protein-signaling-16-restrains-apoptosis-in-colorectal-cancer-through-disrupting-traf6-tab2-tak1-jnkp38-mapk-signaling/342934/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/regulator-of-g-protein-signaling-16-restrains-apoptosis-in-colorectal-cancer-through-disrupting-traf6-tab2-tak1-jnkp38-mapk-signaling/342934.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is apoptosis resistance important in colorectal cancer progression?","Question",{"text":63,"@type":64},"Apoptotic cell death limits tumor growth, while resistance to apoptosis is a pivotal step in tumor progression. Dysregulated apoptosis regulators contribute to this resistance and worsen outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the study identify as a key regulator in colorectal cancer?",{"text":68,"@type":64},"The study focused on RGS proteins in CRC and identified RGS16 as a prospective diagnostic and therapeutic target based on its expression pattern and clinical associations.",{"name":70,"@type":61,"acceptedAnswer":71},"How does RGS16 restrain apoptosis according to the proposed mechanism?",{"text":72,"@type":64},"RGS16 restrains JNK/p38-mediated apoptosis by disrupting the recruitment of TAB2/TAK1 to TRAF6, thereby affecting downstream apoptotic signaling in CRC cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342934,1790177097,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nRegulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/ p38 MAPK signaling  \nHao Shen 1,2,4, Jie Yuan1,3,4, Dafeng Tong1,4, Bingchen Chen 1, Enda Yu1, Guanglei Chen3, Cheng Peng3, Wenjun Chang2 ✉, Jifu E 1 ✉ and Fuao Cao 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Colorectal cancer (CRC) remains a major global cause of cancer-related mortality, lacking effective biomarkers and therapeutic targets. Revealing the critical pathogenic factors of CRC and the underlying mechanisms would offer potential therapeutic strategies for clinical application. G protein signaling (RGS) protein family modulators play essential role within regulating downstream signaling of GPCR receptors, with function in cancers unclear. Our study focused on the expression patterns of RGS proteins in CRC, identifying Regulator of G protein signaling 16 (RGS16) as a prospective diagnostic and therapeutic target. Analyzing 899 CRC tissues revealed elevated RGS16 levels, correlating with clinicopathological features and CRC prognosis by immunohistochemistry (IHC) combined with microarray. We conﬁrmed the elevated RGS16 protein level in CRC, and found that patients with RGS16-high tumors exhibited decreased disease-speciﬁc survival (DSS) and disease-free survival (DFS) compared to those with low RGS16 expression. Functional assays demonstrated that RGS16 promoted the CRC progression, knockdown of RGS16 led to signiﬁcantly increased apoptosis rates of CRC in vitro and in vivo. Notably, we also conﬁrmed these phenotypes of RGS16 in organoids originated from resected primary human CRC tissues. Mechanistically, RGS16 restrained JNK/P38-mediated apoptosis in CRC cells through disrupting the recruitment of TAB2/TAK1 to TRAF6 . This study provides insights into addressing the |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| challenges posed by CRC, offering avenues for clinical translation. |  |  |\n|  | Cell Death and Disease (2024)15:438; [https://doi.org/10.1038/s41419-024-06803-6](https://doi.org/10.1038/s41419-024-06803-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nColorectal cancer (CRC), constituting a highly prevalent malignancy, serves as a signiﬁcant contributor to global morbidity and mortality. Notably, CRC occupies the second position in terms of cancer-related mortality on global scale, it also stands third in terms of incidence rate among all malignancies [1] . Currently, surgical intervention stands as the cornerstone in the treatment of early-stage CRC patients, achieving a commendable 5-year survival rate exceeding 90% . This success is attributed to advancements in surgical techniques and conventional modalities like radiation, chemotherapy, and neoadjuvant therapy. However, for individuals afﬂicted with stage IV colon and rectal cancers, the 5-year survival rate plummets to a mere 11% and 15%, respectively [2–4] . Therefore, the identiﬁcation of innovative and distinctive molecules capable of accurately prognosticating CRC outcomes, along with the exploration of novel therapeutic targets, assumes paramount importance in mitigating the mortality burden associated with this ailment.  \nEvading cell death is widely recognized as a hallmark of cancer [5] . Apoptotic cell death is essential for the limitation of tumor growth. Nevertheless, the resistance to apoptosis, arising from  \ndysregulated expression of molecules involved in its regulation and mediation, represents a pivotal step in tumor progression [6] . Therefore, elucidating the oncogenic targets, unraveling the molecular processes underlying tumor cells’ resistance to apoptosis can offer novel insights into tumorigenesis and therapeutic approaches.  \nThe regulator of G protein signaling (RGS) protein family, characterized by a conserved RGS homology (RH) domain [7], interacts with G prot","cbCaibSlMU5roiRR","https://ap.wps.com/l/cbCaibSlMU5roiRR","pdf",6615486,13,"English","# Introduction\n## Background and clinical need\n## Apoptosis and cancer progression\n## RGS proteins and GPCR signaling\n## RGS16 controversy in CRC","[{\"question\":\"Why is apoptosis resistance important in colorectal cancer progression?\",\"answer\":\"Apoptotic cell death limits tumor growth, while resistance to apoptosis is a pivotal step in tumor progression. Dysregulated apoptosis regulators contribute to this resistance and worsen outcomes.\"},{\"question\":\"What did the study identify as a key regulator in colorectal cancer?\",\"answer\":\"The study focused on RGS proteins in CRC and identified RGS16 as a prospective diagnostic and therapeutic target based on its expression pattern and clinical associations.\"},{\"question\":\"How does RGS16 restrain apoptosis according to the proposed mechanism?\",\"answer\":\"RGS16 restrains JNK/p38-mediated apoptosis by disrupting the recruitment of TAB2/TAK1 to TRAF6, thereby affecting downstream apoptotic signaling in CRC cells.\"}]","Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling | PDF",1790048916,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84d2443e10a1a04dfbfdcc930b49370d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b2d4c5c65ebe1957d20f17d29d718c8.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d71fabcd106ce4a9f3c7ed830ddc2afc.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98bdc3674818a6e87f974cc41b03a68c.webp",980,1301]